title: Anti-NK antibodies injected into recipient mice enhance engraftment and chimerism after allogeneic transplantation of fetal liver stem cells.
abstract: Natural killer (NK) cells have been shown to play a role in the phenomenon of resistance to transplantation of allogeneic stem cells. To explore and prevent such resistance, we treated severe combined immunodeficiency mice (SCID) with anti-NK antibodies and analysed the improved engraftment of stem cells induced by this treatment. Two groups of nine SCID mice (H-2d) were compared: group A received two injections of anti-asialo GM1 rabbit antibodies (anti-NK) on days 1 and 4; group B received two injections of normal rabbit serum. All mice were injected intravenously with 7 x 10(6) fetal liver cells from B6 mice (H-2b) on day 2. One month after fetal liver cell transplantation, all mice from group A demonstrated engraftment and chimerism; at this time, donor cells accounted for more than 50% of peripheral blood mononuclear cells (PBMC). In contrast, in group B, only one mouse had 26% of donor cells among PBMC and all other mice had less than 10%. At two months, results were virtually identical in group A (over 72% of donor cells among PBMC from all mice) and slightly improved in group B (0-38% of donor cells). After the third month and continuously until the 12th month, the stability of chimerism was established in group A (over 55% of donor cells in 7 of the 9 mice) but had virtually disappeared in group B (0-2% of donor cells in all mice). Tissue analysis demonstrated the improved reconstitution of the thymus and the spleen in mice from group A. The proliferative responses of spleen cells to phytomitogens were significantly higher in all mice from group A than in any mouse from group B. Skin allografts from a third party (H-2k) were rejected within 10 days by group A mice but not by group B mice, one year after fetal liver cell transplantation. On the whole, anti-NK antibodies were able to improve engraftment, chimerism and stability of allogeneic stem cell transplants.
authors.affiliation: Department of Transplantation and Clinical Immunology, Hôpital Edouard Herriot, Lyon, France.
authors.forename: J
authors.initials: J
authors.lastname: Chargui
authors.forename: M J
authors.initials: MJ
authors.lastname: Moya
authors.forename: K
authors.initials: K
authors.lastname: Sanhadji
authors.forename: N
authors.initials: N
authors.lastname: Blanc-Brunat
authors.forename: J L
authors.initials: JL
authors.lastname: Touraine
mesh_terms: D000818:Animals; D000906:Antibodies / Q000276:immunology*; D017690:Cell Transplantation; D016332:Fetal Tissue Transplantation; D006084:Graft Rejection; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007694:Killer Cells, Natural / Q000502:physiology*; D007958:Leukocyte Count; D008099:Liver / Q000166:cytology*; D008213:Lymphocyte Activation; D051379:Mice; D016513:Mice, SCID; D011817:Rabbits; D033581:Stem Cell Transplantation
chemical_list: D000906:Antibodies; D007074:Immunoglobulin G; D007075:Immunoglobulin M